Minerva Surgical (UTRS) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends UTRS vs. NYXH, STVN, SYK, BSX, MMM, BDX, RMD, DXCM, WST, and PODDShould you be buying Minerva Surgical stock or one of its competitors? The main competitors of Minerva Surgical include Nyxoah (NYXH), Stevanato Group (STVN), Stryker (SYK), Boston Scientific (BSX), 3M (MMM), Becton, Dickinson and Company (BDX), ResMed (RMD), DexCom (DXCM), West Pharmaceutical Services (WST), and Insulet (PODD). These companies are all part of the "surgical & medical instruments" industry. Minerva Surgical vs. Nyxoah Stevanato Group Stryker Boston Scientific 3M Becton, Dickinson and Company ResMed DexCom West Pharmaceutical Services Insulet Nyxoah (NASDAQ:NYXH) and Minerva Surgical (NASDAQ:UTRS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, community ranking, institutional ownership, earnings, valuation and dividends. Is NYXH or UTRS more profitable? Minerva Surgical has a net margin of 0.00% compared to Nyxoah's net margin of -1,043.93%. Minerva Surgical's return on equity of 0.00% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,043.93% -51.68% -40.11% Minerva Surgical N/A N/A N/A Which has more risk & volatility, NYXH or UTRS? Nyxoah has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, Minerva Surgical has a beta of 4.73, meaning that its share price is 373% more volatile than the S&P 500. Does the media favor NYXH or UTRS? In the previous week, Nyxoah had 6 more articles in the media than Minerva Surgical. MarketBeat recorded 6 mentions for Nyxoah and 0 mentions for Minerva Surgical. Nyxoah's average media sentiment score of 0.32 beat Minerva Surgical's score of 0.00 indicating that Nyxoah is being referred to more favorably in the media. Company Overall Sentiment Nyxoah Neutral Minerva Surgical Neutral Does the MarketBeat Community favor NYXH or UTRS? Nyxoah received 30 more outperform votes than Minerva Surgical when rated by MarketBeat users. Likewise, 71.15% of users gave Nyxoah an outperform vote while only 41.18% of users gave Minerva Surgical an outperform vote. CompanyUnderperformOutperformNyxoahOutperform Votes3771.15% Underperform Votes1528.85% Minerva SurgicalOutperform Votes741.18% Underperform Votes1058.82% Which has better valuation & earnings, NYXH or UTRS? Minerva Surgical has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.70MN/A-$46.77M-$1.87-4.43Minerva Surgical$50.29M0.00-$34.11M-$8.21N/A Do analysts rate NYXH or UTRS? Nyxoah presently has a consensus price target of $17.00, indicating a potential upside of 105.31%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than Minerva Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Minerva Surgical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNyxoah beats Minerva Surgical on 8 of the 14 factors compared between the two stocks. Ad InvestorPlaceWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.Click here now to watch the full briefing and discover the steps to take today. Get Minerva Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTRS vs. The Competition Export to ExcelMetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$4.45B$5.14B$8.84BDividend YieldN/A36.79%5.05%4.07%P/E RatioN/A22.61125.0517.04Price / SalesN/A43.701,232.2287.12Price / CashN/A52.2739.9936.27Price / BookN/A5.806.956.36Net Income-$34.11M$13.76M$119.41M$226.00M Minerva Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTRSMinerva SurgicalN/AN/AN/AN/A$0.00$50.29M0.00174NYXHNyxoah2.9115 of 5 stars$8.28+0.9%$17.00+105.3%+65.6%$0.00$4.70M-4.43146Gap UpSTVNStevanato Group1.1484 of 5 stars€19.62+7.4%N/A-27.0%$0.00$1.17B41.745,635SYKStryker4.9425 of 5 stars$389.88+1.1%$393.65+1.0%+32.8%$148.63B$20.50B41.5952,000Analyst RevisionPositive NewsBSXBoston Scientific4.6192 of 5 stars$91.54+1.5%$93.39+2.0%+65.5%$134.92B$14.24B74.5248,000MMM3M4.868 of 5 stars$127.32-0.4%$144.87+13.8%+35.5%$69.33B$32.68B16.1485,000Positive NewsBDXBecton, Dickinson and Company4.9891 of 5 stars$225.21+1.3%$283.00+25.7%-4.6%$65.10B$20.18B37.9473,000Positive NewsRMDResMed4.8137 of 5 stars$243.60+0.8%$225.70-7.3%+59.7%$35.76B$4.69B31.999,980Positive NewsDXCMDexCom4.9847 of 5 stars$74.48-1.0%$104.59+40.4%-31.6%$29.09B$3.62B45.059,600Positive NewsWSTWest Pharmaceutical Services4.968 of 5 stars$320.28+2.8%$460.33+43.7%-9.3%$23.19B$2.95B47.5210,600PODDInsulet4.4125 of 5 stars$262.99-1.3%$253.27-3.7%+45.0%$18.45B$1.70B45.033,000Positive News Related Companies and Tools Related Companies Nyxoah Alternatives Stevanato Group Alternatives Stryker Alternatives Boston Scientific Alternatives 3M Alternatives Becton, Dickinson and Company Alternatives ResMed Alternatives DexCom Alternatives West Pharmaceutical Services Alternatives Insulet Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:UTRS) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
